RetinalGenix Technologies (RTGN) Total Liabilities (2020 - 2026)

RetinalGenix Technologies (RTGN) has 7 years of Total Liabilities data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 52.62% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 52.62% YoY), and the FY2025 full-year result was $2.3 million, up 57.26% from the prior year.
• Total Liabilities improved to $2.6 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.6 million in Q1 2026 to a low of $675202.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Total Liabilities.
• Peak annual rise in Total Liabilities reached 163.18% in 2023, while the deepest fall reached 1.89% in 2023.
• Tracing RTGN's Total Liabilities over 5 years: stood at $1.1 million in 2022, then soared by 31.51% to $1.4 million in 2023, then advanced by 5.1% to $1.5 million in 2024, then soared by 57.26% to $2.3 million in 2025, then rose by 10.34% to $2.6 million in 2026.
• Business Quant data shows RTGN's Total Liabilities at $2.6 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.